Combination Immunotherapy of Squamous Cell Carcinoma of the Head and Neck
Author(s) -
José Luís Barrera,
Emma Verástegui,
Abelardo Meneses,
Juan W Zinser,
Horacio Astudillode la Vega,
John W. Hadden
Publication year - 2000
Publication title -
archives of otolaryngology - head and neck surgery
Language(s) - English
Resource type - Journals
eISSN - 1538-361X
pISSN - 0886-4470
DOI - 10.1001/archotol.126.3.345
Subject(s) - medicine , cyclophosphamide , gastroenterology , radiation therapy , adverse effect , rash , head and neck squamous cell carcinoma , chemotherapy , head and neck cancer
To test the efficacy of a natural cytokine mixture (IRX-2), cyclophosphamide, indomethacin, and zinc to induce immune regression of squamous cell carcinoma (SCC) of the head and neck (H&N) prior to conventional therapy and to characterize the responses.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom